199 related articles for article (PubMed ID: 8437017)
41. Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications.
Hiraishi Y; Kato S; Ishihara T; Takano T
J Med Genet; 1992 Dec; 29(12):897-901. PubMed ID: 1362223
[TBL] [Abstract][Full Text] [Related]
42. Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy.
Bushby KM; Cleghorn NJ; Curtis A; Haggerty ID; Nicholson LV; Johnson MA; Harris JB; Bhattacharya SS
Hum Genet; 1991 Dec; 88(2):195-9. PubMed ID: 1757094
[TBL] [Abstract][Full Text] [Related]
43. Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.
Morandi L; Mora M; Confalonieri V; Barresi R; Di Blasi C; Brugnoni R; Bernasconi P; Mantegazza R; Dworzak F; Antozzi C
J Neurol Sci; 1995 Oct; 132(2):146-55. PubMed ID: 8543940
[TBL] [Abstract][Full Text] [Related]
44. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
45. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion.
Prior TW; Bartolo C; Papp AC; Snyder PJ; Sedra MS; Burghes AH; Kissel JT; Luquette MH; Tsao CY; Mendell JR
Neurology; 1997 Feb; 48(2):486-8. PubMed ID: 9040743
[TBL] [Abstract][Full Text] [Related]
46. Becker muscular dystrophy: correlation of deletion type with clinical severity.
Norman AM; Thomas NS; Kingston HM; Harper PS
J Med Genet; 1990 Apr; 27(4):236-9. PubMed ID: 2325103
[TBL] [Abstract][Full Text] [Related]
47. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history.
Bushby KM; Gardner-Medwin D
J Neurol; 1993 Feb; 240(2):98-104. PubMed ID: 8437027
[TBL] [Abstract][Full Text] [Related]
48. [Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].
Takeshima Y; Matsuo M
Nihon Rinsho; 1997 Dec; 55(12):3120-5. PubMed ID: 9436421
[TBL] [Abstract][Full Text] [Related]
49. Deletion status and intellectual impairment in Duchenne muscular dystrophy.
Bushby KM; Appleton R; Anderson LV; Welch JL; Kelly P; Gardner-Medwin D
Dev Med Child Neurol; 1995 Mar; 37(3):260-9. PubMed ID: 7890131
[TBL] [Abstract][Full Text] [Related]
50. [Correlation of cardiac muscle involvement and the dystrophin gene abnormality in Becker muscular dystrophy].
Yazaki M; Nakamura A; Yoshida K; Ikeda S
Nihon Rinsho; 1997 Dec; 55(12):3142-7. PubMed ID: 9436425
[TBL] [Abstract][Full Text] [Related]
51. Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients.
Uwineza A; Hitayezu J; Murorunkwere S; Ndinkabandi J; Kalala Malu CK; Caberg JH; Dideberg V; Bours V; Mutesa L
J Trop Pediatr; 2014 Apr; 60(2):112-7. PubMed ID: 24213305
[TBL] [Abstract][Full Text] [Related]
52. Interrelationship between gene, its product and phenotype in Duchenne and Becker muscular dystrophy.
Hausmanowa-Petrusewicz I; Zaremba J; Fidziańska A; Zimowski J; Bisko M; Badurska B; Fidziańska E; Lusakowska A; Borkowska J
Acta Neurobiol Exp (Wars); 1993; 53(1):297-303. PubMed ID: 8317263
[TBL] [Abstract][Full Text] [Related]
53. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene].
Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L
Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443
[TBL] [Abstract][Full Text] [Related]
54. Pattern of deletions of the dystrophin gene in Mexican Duchenne/Becker muscular dystrophy patients: the use of new designed primers for the analysis of the major deletion "hot spot" region.
Coral-Vazquez R; Arenas D; Cisneros B; Peñaloza L; Salamanca F; Kofman S; Mercado R; Montañez C
Am J Med Genet; 1997 Jun; 70(3):240-6. PubMed ID: 9188659
[TBL] [Abstract][Full Text] [Related]
55. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
56. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
[TBL] [Abstract][Full Text] [Related]
57. [Gene deletion analysis in molecular diagnosis of Duchenne-Becker muscular dystrophy].
Endreffy E; László A; Kálmán M; Krenács T; Raskó I
Orv Hetil; 1994 Feb; 135(8):399-403. PubMed ID: 8139842
[TBL] [Abstract][Full Text] [Related]
58. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
59. Early onset autosomal dominant progressive muscular dystrophy presenting in childhood as a Becker phenotype--the importance of dystrophin and molecular genetic analysis.
Miller G; Beggs AH; Towfighi J
Neuromuscul Disord; 1992; 2(2):121-4. PubMed ID: 1422199
[TBL] [Abstract][Full Text] [Related]
60. Characterization of deletions in the dystrophin gene giving mild phenotypes.
Love DR; Flint TJ; Marsden RF; Bloomfield JF; Daniels RJ; Forrest SM; Gabrielli O; Giorgi P; Novelli G; Davies KE
Am J Med Genet; 1990 Sep; 37(1):136-42. PubMed ID: 2240031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
